Tony S. K. Mok, MD, BMSc, FRCPC, FASCO
Advertisement

Tony S.K. Mok, BMSc, MD, FRCP(C), FHKCP, FHKAM, FASCO, is chairman of the Department of Clinical Oncology and the Li Shu Fan Professor of Clinical Oncology at the Chinese University of Hong Kong
Articles by Tony S. K. Mok, MD, BMSc, FRCPC, FASCO
Advertisement
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5

